Sigilon Therapeutics Receives Orphan Drug Designation for SIG-007 for the Treatment of Fabry Disease
CAMBRIDGE, Mass., March 05, 2021 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company…
CAMBRIDGE, Mass., March 05, 2021 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company…
— Company to host conference call on March 9th, 2021, at 8:00 a.m. ET —…
WARREN, N.J., March 05, 2021 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. PUBLICATION RELATING TO A TRANSPARENCY NOTIFICATION (ARTICLE 14, 1ST PARAGRAPH,…
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MARCH 2021 at 11.00 EET Orion Corporation: Managers’ transactions…
The knee bandage with the name Caresole Circa Knee can basically be worn by every…
Company announcement, Helsinki, 5 March 2021 at 09.00 am (EET) Nexstim Plc Publishes 2020 Annual…
SAN DIEGO, March 04, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), announced…
Phase III trial patient enrollment for balixafortide completed in Q4 2020 despite COVID-19. Results expected…
Shannon Klinger, Chief Legal Officer, to leave Novartis on March 15, 2021 Thomas Kendris appointed…